244 related articles for article (PubMed ID: 16785110)
1. Botulinum neurotoxin - from laboratory to bedside.
Foster KA; Bigalke H; Aoki KR
Neurotox Res; 2006 Apr; 9(2-3):133-40. PubMed ID: 16785110
[TBL] [Abstract][Full Text] [Related]
2. The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection.
Shone C; Ferreira J; Boyer A; Cirino N; Egan C; Evans E; Kools J; Sharma S
Neurotox Res; 2006 Apr; 9(2-3):205-16. PubMed ID: 16785119
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
Popoff MR; Marvaud JC; Raffestin S
Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
[TBL] [Abstract][Full Text] [Related]
4. Future aspects of botulinum neurotoxins.
Aoki KR
J Neural Transm (Vienna); 2008; 115(4):567-73. PubMed ID: 17557128
[TBL] [Abstract][Full Text] [Related]
5. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.
Turton K; Chaddock JA; Acharya KR
Trends Biochem Sci; 2002 Nov; 27(11):552-8. PubMed ID: 12417130
[TBL] [Abstract][Full Text] [Related]
6. Xeomin: an innovative new botulinum toxin type A.
Frevert J
Eur J Neurol; 2009 Dec; 16 Suppl 2():11-3. PubMed ID: 20002741
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin--mechanisms of action and clinical use in spasticity.
Barnes M
J Rehabil Med; 2003 May; (41 Suppl):56-9. PubMed ID: 12817658
[TBL] [Abstract][Full Text] [Related]
8. [Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect].
Poulain B; Humeau Y
Ann Readapt Med Phys; 2003 Jul; 46(6):265-75. PubMed ID: 12928128
[TBL] [Abstract][Full Text] [Related]
9. Temporal characteristics of botulinum neurotoxin therapy.
Lebeda FJ; Cer RZ; Stephens RM; Mudunuri U
Expert Rev Neurother; 2010 Jan; 10(1):93-103. PubMed ID: 20021324
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.
Pirazzini M; Rossetto O; Eleopra R; Montecucco C
Pharmacol Rev; 2017 Apr; 69(2):200-235. PubMed ID: 28356439
[TBL] [Abstract][Full Text] [Related]
11. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
Dolimbek BZ; Jankovic J; Atassi MZ
Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
[TBL] [Abstract][Full Text] [Related]
12. Clostridial neurotoxins: structure-function led design of new therapeutics.
Chaddock JA; Marks PM
Cell Mol Life Sci; 2006 Mar; 63(5):540-51. PubMed ID: 16416025
[TBL] [Abstract][Full Text] [Related]
13. Diffusion, spread, and migration of botulinum toxin.
Ramirez-Castaneda J; Jankovic J; Comella C; Dashtipour K; Fernandez HH; Mari Z
Mov Disord; 2013 Nov; 28(13):1775-83. PubMed ID: 23868503
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin and other new approaches to migraine therapy.
Ashkenazi A; Silberstein SD
Annu Rev Med; 2004; 55():505-18. PubMed ID: 14746533
[TBL] [Abstract][Full Text] [Related]
15. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip.
Tehran DA; Pirazzini M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.
Fredrick CM; Lin G; Johnson EA
Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455330
[TBL] [Abstract][Full Text] [Related]
17. [Botulinum toxin: clinical uses and anesthetic implications].
Vidal-Marcos A; Sanz-García M; Infante-Crespo B; Ruiz-Castro M; Rustarazo-Pérez MT; Palma-Gámiz MA
Rev Esp Anestesiol Reanim; 1996; 43(6):208-11. PubMed ID: 8756235
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin: structure and pharmacology.
Hambleton P
Eur Arch Otorhinolaryngol; 1994 Dec; ():S200-2. PubMed ID: 10774350
[No Abstract] [Full Text] [Related]
19. Injectable neuromodulatory agents: botulinum toxin therapy.
Frenkl TL; Rackley RR
Urol Clin North Am; 2005 Feb; 32(1):89-99. PubMed ID: 15698881
[TBL] [Abstract][Full Text] [Related]
20. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.
Chen S
Toxins (Basel); 2012 Oct; 4(10):913-39. PubMed ID: 23162705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
